PanTher Therapeutics

About:

PanTher Therapeutics features treatment platform designed to enhance therapeutic response with minimal side effects.

Website: https://www.panthertx.com/

Twitter/X: PanTherTx

Top Investors: MedTech Innovator, Cancer Prevention and Research Institute of Texas, Kli Capital, Sidecar Angels, Catalyst Health Ventures

Description:

PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.

Total Funding Amount:

$21.3M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)panthertx.com

Founders:

David Ting, Elazer Edelman, Laura Indolfi

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai